Delivery Order SPE2DB22D2206-SPE2DB24FGR73
- Not listed
- This federal contract award, valued at $9,660.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of INQOVI 35 MG-100 MG tablets, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of November 5, 2024. The contract is not set aside for any specific business type. Amerisourcebergen, through its Corporate Office Division, has been awarded numerous...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,997.42, is for the delivery of the drug Inqovi 35 mg-100 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of January 21, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,830.47 firm fixed price delivery order is for the supply of the medication Inqovi 35 mg-100 mg tablets. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
- This federal contract award is for the delivery of INQOVI 35 MG-100 MG TABLET pharmaceutical products to the Defense Logistics Agency (DLA). The $4,830.47 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 6, 2024, with a completion date of September 27, 2024. The contract is not set aside for a specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the supply of the pharmaceutical product INQOVI 35 MG-100 MG TABLET UU 5S to the Defense Logistics Agency (DLA). The contract, valued at $4,830.47, is a firm fixed-price delivery order with a period of performance through June 18, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
- This federal contract award, with identification number SPE2DB22D1103|SPE2DB24FTLF1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,830.47 firm fixed-price delivery order is for the supply of INQOVI 35 MG-100 MG TABLET, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for pharmaceutical and medical supply products. The contract is a Delivery Order valued at $1,577.58 with a completion date of November 6, 2020. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) with a delivery order valued at $1,443.79. The contract has a period of performance through March 12, 2024 and is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award is to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, to provide the medication INQOVI 35 MG-100 MG Tablet to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,830.47, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a Firm Fixed Price valued at $1,392.44. The contract is for pharmaceutical and medical supply products to support the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to provide a...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGR73Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $14,491.41 delivery order is for the supply of INQOVI 35 MG-100 MG tablets, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of May 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, the company holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award was not set aside for any socioeconomic program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.5k | 4/15/24 |